FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:CACNA2D1-PTPN12 (FusionGDB2 ID:12405)

Fusion Gene Summary for CACNA2D1-PTPN12

check button Fusion gene summary
Fusion gene informationFusion gene name: CACNA2D1-PTPN12
Fusion gene ID: 12405
HgeneTgene
Gene symbol

CACNA2D1

PTPN12

Gene ID

781

5782

Gene namecalcium voltage-gated channel auxiliary subunit alpha2delta 1protein tyrosine phosphatase non-receptor type 12
SynonymsCACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3PTP-PEST|PTPG1
Cytomap

7q21.11

7q11.23

Type of geneprotein-codingprotein-coding
Descriptionvoltage-dependent calcium channel subunit alpha-2/delta-1calcium channel, L type, alpha 2 polypeptidecalcium channel, voltage-dependent, alpha 2/delta subunit 1dihydropyridine-sensitive L-type, calcium channel alpha-2/delta subunitvoltage-gated calciutyrosine-protein phosphatase non-receptor type 12protein-tyrosine phosphatase G1
Modification date2020031320200329
UniProtAcc

P54289

.
Ensembl transtripts involved in fusion geneENST00000356860, ENST00000356253, 
ENST00000423588, ENST00000464354, 
ENST00000535308, 		ENST00000248594, 
ENST00000415482, ENST00000435495, 
Fusion gene scores* DoF score6 X 8 X 4=19214 X 11 X 7=1078
# samples 914
** MAII scorelog2(9/192*10)=-1.09310940439148
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(14/1078*10)=-2.94485844580754
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: CACNA2D1 [Title/Abstract] AND PTPN12 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointCACNA2D1(81964451)-PTPN12(77200395), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCACNA2D1

GO:0006816

calcium ion transport

1309651|11160515

HgeneCACNA2D1

GO:0051924

regulation of calcium ion transport

1309651

TgenePTPN12

GO:0006470

protein dephosphorylation

27134172

TgenePTPN12

GO:0035335

peptidyl-tyrosine dephosphorylation

27134172


check buttonFusion gene breakpoints across CACNA2D1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across PTPN12 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4SARCTCGA-K1-A6RT-01ACACNA2D1chr7

81964451

-PTPN12chr7

77200395

+


Top

Fusion Gene ORF analysis for CACNA2D1-PTPN12

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
In-frameENST00000356860ENST00000248594CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000356860ENST00000415482CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000356860ENST00000435495CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
In-frameENST00000356253ENST00000248594CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000356253ENST00000415482CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000356253ENST00000435495CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
In-frameENST00000423588ENST00000248594CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000423588ENST00000415482CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
5CDS-5UTRENST00000423588ENST00000435495CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-3CDSENST00000464354ENST00000248594CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-5UTRENST00000464354ENST00000415482CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-5UTRENST00000464354ENST00000435495CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-3CDSENST00000535308ENST00000248594CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-5UTRENST00000535308ENST00000415482CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+
intron-5UTRENST00000535308ENST00000435495CACNA2D1chr7

81964451

-PTPN12chr7

77200395

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000356860CACNA2D1chr781964451-ENST00000248594PTPN12chr777200395+36686333392876845
ENST00000356253CACNA2D1chr781964451-ENST00000248594PTPN12chr777200395+35855502562793845
ENST00000423588CACNA2D1chr781964451-ENST00000248594PTPN12chr777200395+35865512572794845

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000356860ENST00000248594CACNA2D1chr781964451-PTPN12chr777200395+0.0002480060.999752
ENST00000356253ENST00000248594CACNA2D1chr781964451-PTPN12chr777200395+0.0002670080.99973303
ENST00000423588ENST00000248594CACNA2D1chr781964451-PTPN12chr777200395+0.0002670370.9997329

Top

Fusion Genomic Features for CACNA2D1-PTPN12


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)
CACNA2D1chr781964450-PTPN12chr777200394+3.59E-060.9999964
CACNA2D1chr781964450-PTPN12chr777200394+3.59E-060.9999964

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for CACNA2D1-PTPN12


check button Go to

FGviewer for the breakpoints of chr7:81964451-chr7:77200395

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
CACNA2D1

P54289

.
FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250}.FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgenePTPN12chr7:81964451chr7:77200395ENST0000043549501728_2930651.0DomainTyrosine-protein phosphatase
TgenePTPN12chr7:81964451chr7:77200395ENST00000248594018231_23733.0781.0RegionSubstrate binding
TgenePTPN12chr7:81964451chr7:77200395ENST0000024859401863_6733.0781.0RegionSubstrate binding
TgenePTPN12chr7:81964451chr7:77200395ENST00000435495017231_2370651.0RegionSubstrate binding
TgenePTPN12chr7:81964451chr7:77200395ENST0000043549501763_670651.0RegionSubstrate binding

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-339253_43098.01104.0DomainVWFA
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-339446_55698.01104.0DomainNote=Cache
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-339253_43098.01092.0DomainVWFA
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-339446_55698.01092.0DomainNote=Cache
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-339259_26398.01104.0MotifNote=MIDAS-like motif
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-339259_26398.01092.0MotifNote=MIDAS-like motif
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-3391095_110398.01104.0Topological domainCytoplasmic
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-33925_107398.01104.0Topological domainExtracellular
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-3391095_110398.01092.0Topological domainCytoplasmic
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-33925_107398.01092.0Topological domainExtracellular
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356253-3391074_109498.01104.0TransmembraneHelical
HgeneCACNA2D1chr7:81964451chr7:77200395ENST00000356860-3391074_109498.01092.0TransmembraneHelical
TgenePTPN12chr7:81964451chr7:77200395ENST0000024859401828_29333.0781.0DomainTyrosine-protein phosphatase


Top

Fusion Gene Sequence for CACNA2D1-PTPN12


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>In-frame_ENST00000356860_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(transcript)=3668nt_BP=633nt
AGGGAGGAAACCGAGAGGGAGAGCGAGAGCGCGCGAGCGCCGGCGGGCTCGCCGAGGTCTGTTTCCAAAGTCGCCCTTGATGGCGGCGGA
GGCAAGGCGGCCGCGGCGCGGAGCAGCCGACGCACGCTAGTGGGTCCGCCCGCCACCGCCCCTTCCTCGGCGTCCGCTCCCGCCCTTGCC
GTCCCCCGCGCGGCTCCGCGCCTCGGGCCCCGGGCGCAGCCAGCCCTCCAGACGCCCGCGGTCCCGGCGGCGTGTGCTGCTCTTCCTCCG
CCCGCGGTTTCCAGCGCCGCTCCTTCCCCCGCTTGGGCAGGGAGGGGGCATTGATCTTCGATCGCGAAGATGGCTGCTGGCTGCCTGCTG
GCCTTGACTCTGACACTTTTCCAATCTTTGCTCATCGGCCCCTCGTCGGAGGAGCCGTTCCCTTCGGCCGTCACTATCAAATCATGGGTG
GATAAGATGCAAGAAGACCTTGTCACACTGGCAAAAACAGCAAGTGGAGTCAATCAGCTTGTTGATATTTATGAGAAATATCAAGATTTG
TATACTGTGGAACCAAATAATGCACGCCAGCTGGTAGAAATTGCAGCCAGGGATATTGAGAAACTTCTGAGCAACAGATCTAAAGCCCTG
GTGCGGTTAAGAAGATTGTCTACCAAATATAGAACAGAAAAGATATATCCCACAGCCACTGGAGAAAAAGAAGAAAATGTTAAAAAGAAC
AGATACAAGGACATACTGCCATTTGATCACAGCCGAGTTAAATTGACATTAAAGACTCCTTCACAAGATTCAGACTATATCAATGCAAAT
TTTATAAAGGGCGTCTATGGGCCAAAAGCATATGTAGCAACTCAAGGACCTTTAGCAAATACAGTAATAGATTTTTGGAGGATGATATGG
GAGTATAATGTTGTGATCATTGTAATGGCCTGCCGAGAATTTGAGATGGGAAGGAAAAAATGTGAGCGCTATTGGCCTTTGTATGGAGAA
GACCCCATAACGTTTGCACCATTTAAAATTTCTTGTGAGGATGAACAAGCAAGAACAGACTACTTCATCAGGACACTCTTACTTGAATTT
CAAAATGAATCTCGTAGGCTGTATCAGTTTCATTATGTGAACTGGCCAGACCATGATGTTCCTTCATCATTTGATTCTATTCTGGACATG
ATAAGCTTAATGAGGAAATATCAAGAACATGAAGATGTTCCTATTTGTATTCATTGCAGTGCAGGCTGTGGAAGAACAGGTGCCATTTGT
GCCATAGATTATACGTGGAATTTACTAAAAGCTGGGAAAATACCAGAGGAATTTAATGTATTTAATTTAATACAAGAAATGAGAACACAA
AGGCATTCTGCAGTACAAACAAAGGAGCAATATGAACTTGTTCATAGAGCTATTGCCCAACTGTTTGAAAAACAGCTACAACTATATGAA
ATTCATGGAGCTCAGAAAATTGCTGATGGAGTGAATGAAATTAACACTGAAAACATGGTCAGCTCCATAGAGCCTGAAAAACAAGATTCT
CCTCCTCCAAAACCACCAAGGACCCGCAGTTGCCTTGTTGAAGGGGATGCTAAAGAAGAAATACTGCAGCCACCGGAACCTCATCCAGTG
CCACCCATCTTGACACCTTCTCCCCCTTCAGCTTTTCCAACAGTCACTACTGTGTGGCAGGACAATGATAGATACCATCCAAAGCCAGTG
TTGCATATGGTTTCATCAGAACAACATTCAGCAGACCTCAACAGAAACTATAGTAAATCAACAGAACTTCCAGGGAAAAATGAATCAACA
ATTGAACAGATAGATAAAAAATTGGAACGAAATTTAAGTTTTGAGATTAAGAAGGTCCCTCTCCAAGAGGGACCAAAAAGTTTTGATGGG
AACACACTTTTGAATAGGGGACATGCAATTAAAATTAAATCTGCTTCACCTTGTATAGCTGATAAAATCTCTAAGCCACAGGAATTAAGT
TCAGATCTAAATGTCGGTGATACTTCCCAGAATTCTTGTGTGGACTGCAGTGTAACACAATCAAACAAAGTTTCAGTTACTCCACCAGAA
GAATCCCAGAATTCAGACACACCTCCAAGGCCAGACCGCTTGCCTCTTGATGAGAAAGGACATGTAACGTGGTCATTTCATGGACCTGAA
AATGCCATACCCATACCTGATTTATCTGAAGGCAATTCCTCAGATATCAACTATCAAACTAGGAAAACTGTGAGTTTAACACCAAGTCCT
ACAACACAAGTTGAAACACCTGATCTTGTGGATCATGATAACACTTCACCACTCTTCAGAACACCCCTCAGTTTTACTAATCCACTTCAC
TCTGATGACTCAGACTCAGATGAAAGAAACTCTGATGGTGCTGTGACCCAGAATAAAACTAATATTTCAACAGCAAGTGCCACAGTTTCT
GCTGCCACTAGTACTGAAAGCATTTCTACTAGGAAAGTATTGCCAATGTCCATTGCTAGACATAATATAGCAGGAACAACACATTCAGGT
GCTGAAAAAGATGTTGATGTTAGTGAAGATTCACCTCCTCCCCTACCTGAAAGAACTCCTGAATCGTTTGTGTTAGCAAGTGAACATAAT
ACACCTGTAAGATCGGAATGGAGTGAACTTCAAAGTCAGGAACGATCTGAACAAAAAAAGTCTGAAGGCTTGATAACCTCTGAAAATGAG
AAATGTGATCATCCAGCGGGAGGTATTCACTATGAAATGTGCATAGAATGTCCACCTACTTTCAGTGACAAGAGAGAACAAATATCAGAA
AATCCAACAGAAGCCACAGATATTGGTTTTGGTAATCGATGTGGAAAACCCAAAGGACCAAGAGATCCACCTTCAGAATGGACATGATTC
AGGGAGCTAGAAGACACTTTAAGTTATACTGGAAAATTCAGGTGCCACTGAAAGCCAGATTTATAGTATTCCATCTTTAATATGTGGGAC
TAACAGCAGTGTAGATTGTTACCTTAATATTTTTTGCTGGGACCATCTACCTGCCTTATACTACACTTAGGAAAAAGTATTACATATGGT
TTATTTTGAAACTTCAAGTATTATTGCCTTAATGTCTCTTAACCCTGTTACACGCTGCTTGTAGACATGTTAATATAGTAATACCTTTAT
GATATATTGAGTTTAAGGACTACTCTTTTTCTGTTTTATCATGTATGCATTATTTTGTATATGTACAGGGCAAGTAGGTATATAATTTGA
TAAAGTTGCAATTGAAATATTATTAACAGAAGATGTAAGAAATTTCTGCATGGTCTAAATCTTTGTGTACTTTATTTGTAAATTATTTGC
CCTGGAGTTTTAGAAAATAGTTTCTGAATTTTAAACTTGCTGGATTCATGCAGCCAGCTTTGCAGGTTATCAGAGATCAAAGATTGTAAT
AATAATTTTGTAAATTGTAAGCAAAAAGTTATTTTTATATTATATACAGTCTAATTGTTCATCCTAATTGTTCCTGTTTTCATCTAGTCA
GAGATTCAGTAAGTGCCTTGGAACAATATTGAATTCTCTTAGCTTGTGTGTGTTTCTTTAATATTTGAACTCAAGTGGGATTAGAAGACT

>In-frame_ENST00000356860_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(amino acids)=845AA_start in transcript=339_stop in transcript=2876
MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLL
SNRSKALVRLRRLSTKYRTEKIYPTATGEKEENVKKNRYKDILPFDHSRVKLTLKTPSQDSDYINANFIKGVYGPKAYVATQGPLANTVI
DFWRMIWEYNVVIIVMACREFEMGRKKCERYWPLYGEDPITFAPFKISCEDEQARTDYFIRTLLLEFQNESRRLYQFHYVNWPDHDVPSS
FDSILDMISLMRKYQEHEDVPICIHCSAGCGRTGAICAIDYTWNLLKAGKIPEEFNVFNLIQEMRTQRHSAVQTKEQYELVHRAIAQLFE
KQLQLYEIHGAQKIADGVNEINTENMVSSIEPEKQDSPPPKPPRTRSCLVEGDAKEEILQPPEPHPVPPILTPSPPSAFPTVTTVWQDND
RYHPKPVLHMVSSEQHSADLNRNYSKSTELPGKNESTIEQIDKKLERNLSFEIKKVPLQEGPKSFDGNTLLNRGHAIKIKSASPCIADKI
SKPQELSSDLNVGDTSQNSCVDCSVTQSNKVSVTPPEESQNSDTPPRPDRLPLDEKGHVTWSFHGPENAIPIPDLSEGNSSDINYQTRKT
VSLTPSPTTQVETPDLVDHDNTSPLFRTPLSFTNPLHSDDSDSDERNSDGAVTQNKTNISTASATVSAATSTESISTRKVLPMSIARHNI
AGTTHSGAEKDVDVSEDSPPPLPERTPESFVLASEHNTPVRSEWSELQSQERSEQKKSEGLITSENEKCDHPAGGIHYEMCIECPPTFSD

--------------------------------------------------------------
>In-frame_ENST00000356253_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(transcript)=3585nt_BP=550nt
CGGCGGAGGCAAGGCGGCCGCGGCGCGGAGCAGCCGACGCACGCTAGTGGGTCCGCCCGCCACCGCCCCTTCCTCGGCGTCCGCTCCCGC
CCTTGCCGTCCCCCGCGCGGCTCCGCGCCTCGGGCCCCGGGCGCAGCCAGCCCTCCAGACGCCCGCGGTCCCGGCGGCGTGTGCTGCTCT
TCCTCCGCCCGCGGTTTCCAGCGCCGCTCCTTCCCCCGCTTGGGCAGGGAGGGGGCATTGATCTTCGATCGCGAAGATGGCTGCTGGCTG
CCTGCTGGCCTTGACTCTGACACTTTTCCAATCTTTGCTCATCGGCCCCTCGTCGGAGGAGCCGTTCCCTTCGGCCGTCACTATCAAATC
ATGGGTGGATAAGATGCAAGAAGACCTTGTCACACTGGCAAAAACAGCAAGTGGAGTCAATCAGCTTGTTGATATTTATGAGAAATATCA
AGATTTGTATACTGTGGAACCAAATAATGCACGCCAGCTGGTAGAAATTGCAGCCAGGGATATTGAGAAACTTCTGAGCAACAGATCTAA
AGCCCTGGTGCGGTTAAGAAGATTGTCTACCAAATATAGAACAGAAAAGATATATCCCACAGCCACTGGAGAAAAAGAAGAAAATGTTAA
AAAGAACAGATACAAGGACATACTGCCATTTGATCACAGCCGAGTTAAATTGACATTAAAGACTCCTTCACAAGATTCAGACTATATCAA
TGCAAATTTTATAAAGGGCGTCTATGGGCCAAAAGCATATGTAGCAACTCAAGGACCTTTAGCAAATACAGTAATAGATTTTTGGAGGAT
GATATGGGAGTATAATGTTGTGATCATTGTAATGGCCTGCCGAGAATTTGAGATGGGAAGGAAAAAATGTGAGCGCTATTGGCCTTTGTA
TGGAGAAGACCCCATAACGTTTGCACCATTTAAAATTTCTTGTGAGGATGAACAAGCAAGAACAGACTACTTCATCAGGACACTCTTACT
TGAATTTCAAAATGAATCTCGTAGGCTGTATCAGTTTCATTATGTGAACTGGCCAGACCATGATGTTCCTTCATCATTTGATTCTATTCT
GGACATGATAAGCTTAATGAGGAAATATCAAGAACATGAAGATGTTCCTATTTGTATTCATTGCAGTGCAGGCTGTGGAAGAACAGGTGC
CATTTGTGCCATAGATTATACGTGGAATTTACTAAAAGCTGGGAAAATACCAGAGGAATTTAATGTATTTAATTTAATACAAGAAATGAG
AACACAAAGGCATTCTGCAGTACAAACAAAGGAGCAATATGAACTTGTTCATAGAGCTATTGCCCAACTGTTTGAAAAACAGCTACAACT
ATATGAAATTCATGGAGCTCAGAAAATTGCTGATGGAGTGAATGAAATTAACACTGAAAACATGGTCAGCTCCATAGAGCCTGAAAAACA
AGATTCTCCTCCTCCAAAACCACCAAGGACCCGCAGTTGCCTTGTTGAAGGGGATGCTAAAGAAGAAATACTGCAGCCACCGGAACCTCA
TCCAGTGCCACCCATCTTGACACCTTCTCCCCCTTCAGCTTTTCCAACAGTCACTACTGTGTGGCAGGACAATGATAGATACCATCCAAA
GCCAGTGTTGCATATGGTTTCATCAGAACAACATTCAGCAGACCTCAACAGAAACTATAGTAAATCAACAGAACTTCCAGGGAAAAATGA
ATCAACAATTGAACAGATAGATAAAAAATTGGAACGAAATTTAAGTTTTGAGATTAAGAAGGTCCCTCTCCAAGAGGGACCAAAAAGTTT
TGATGGGAACACACTTTTGAATAGGGGACATGCAATTAAAATTAAATCTGCTTCACCTTGTATAGCTGATAAAATCTCTAAGCCACAGGA
ATTAAGTTCAGATCTAAATGTCGGTGATACTTCCCAGAATTCTTGTGTGGACTGCAGTGTAACACAATCAAACAAAGTTTCAGTTACTCC
ACCAGAAGAATCCCAGAATTCAGACACACCTCCAAGGCCAGACCGCTTGCCTCTTGATGAGAAAGGACATGTAACGTGGTCATTTCATGG
ACCTGAAAATGCCATACCCATACCTGATTTATCTGAAGGCAATTCCTCAGATATCAACTATCAAACTAGGAAAACTGTGAGTTTAACACC
AAGTCCTACAACACAAGTTGAAACACCTGATCTTGTGGATCATGATAACACTTCACCACTCTTCAGAACACCCCTCAGTTTTACTAATCC
ACTTCACTCTGATGACTCAGACTCAGATGAAAGAAACTCTGATGGTGCTGTGACCCAGAATAAAACTAATATTTCAACAGCAAGTGCCAC
AGTTTCTGCTGCCACTAGTACTGAAAGCATTTCTACTAGGAAAGTATTGCCAATGTCCATTGCTAGACATAATATAGCAGGAACAACACA
TTCAGGTGCTGAAAAAGATGTTGATGTTAGTGAAGATTCACCTCCTCCCCTACCTGAAAGAACTCCTGAATCGTTTGTGTTAGCAAGTGA
ACATAATACACCTGTAAGATCGGAATGGAGTGAACTTCAAAGTCAGGAACGATCTGAACAAAAAAAGTCTGAAGGCTTGATAACCTCTGA
AAATGAGAAATGTGATCATCCAGCGGGAGGTATTCACTATGAAATGTGCATAGAATGTCCACCTACTTTCAGTGACAAGAGAGAACAAAT
ATCAGAAAATCCAACAGAAGCCACAGATATTGGTTTTGGTAATCGATGTGGAAAACCCAAAGGACCAAGAGATCCACCTTCAGAATGGAC
ATGATTCAGGGAGCTAGAAGACACTTTAAGTTATACTGGAAAATTCAGGTGCCACTGAAAGCCAGATTTATAGTATTCCATCTTTAATAT
GTGGGACTAACAGCAGTGTAGATTGTTACCTTAATATTTTTTGCTGGGACCATCTACCTGCCTTATACTACACTTAGGAAAAAGTATTAC
ATATGGTTTATTTTGAAACTTCAAGTATTATTGCCTTAATGTCTCTTAACCCTGTTACACGCTGCTTGTAGACATGTTAATATAGTAATA
CCTTTATGATATATTGAGTTTAAGGACTACTCTTTTTCTGTTTTATCATGTATGCATTATTTTGTATATGTACAGGGCAAGTAGGTATAT
AATTTGATAAAGTTGCAATTGAAATATTATTAACAGAAGATGTAAGAAATTTCTGCATGGTCTAAATCTTTGTGTACTTTATTTGTAAAT
TATTTGCCCTGGAGTTTTAGAAAATAGTTTCTGAATTTTAAACTTGCTGGATTCATGCAGCCAGCTTTGCAGGTTATCAGAGATCAAAGA
TTGTAATAATAATTTTGTAAATTGTAAGCAAAAAGTTATTTTTATATTATATACAGTCTAATTGTTCATCCTAATTGTTCCTGTTTTCAT
CTAGTCAGAGATTCAGTAAGTGCCTTGGAACAATATTGAATTCTCTTAGCTTGTGTGTGTTTCTTTAATATTTGAACTCAAGTGGGATTA

>In-frame_ENST00000356253_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(amino acids)=845AA_start in transcript=256_stop in transcript=2793
MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLL
SNRSKALVRLRRLSTKYRTEKIYPTATGEKEENVKKNRYKDILPFDHSRVKLTLKTPSQDSDYINANFIKGVYGPKAYVATQGPLANTVI
DFWRMIWEYNVVIIVMACREFEMGRKKCERYWPLYGEDPITFAPFKISCEDEQARTDYFIRTLLLEFQNESRRLYQFHYVNWPDHDVPSS
FDSILDMISLMRKYQEHEDVPICIHCSAGCGRTGAICAIDYTWNLLKAGKIPEEFNVFNLIQEMRTQRHSAVQTKEQYELVHRAIAQLFE
KQLQLYEIHGAQKIADGVNEINTENMVSSIEPEKQDSPPPKPPRTRSCLVEGDAKEEILQPPEPHPVPPILTPSPPSAFPTVTTVWQDND
RYHPKPVLHMVSSEQHSADLNRNYSKSTELPGKNESTIEQIDKKLERNLSFEIKKVPLQEGPKSFDGNTLLNRGHAIKIKSASPCIADKI
SKPQELSSDLNVGDTSQNSCVDCSVTQSNKVSVTPPEESQNSDTPPRPDRLPLDEKGHVTWSFHGPENAIPIPDLSEGNSSDINYQTRKT
VSLTPSPTTQVETPDLVDHDNTSPLFRTPLSFTNPLHSDDSDSDERNSDGAVTQNKTNISTASATVSAATSTESISTRKVLPMSIARHNI
AGTTHSGAEKDVDVSEDSPPPLPERTPESFVLASEHNTPVRSEWSELQSQERSEQKKSEGLITSENEKCDHPAGGIHYEMCIECPPTFSD

--------------------------------------------------------------
>In-frame_ENST00000423588_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(transcript)=3586nt_BP=551nt
GCGGCGGAGGCAAGGCGGCCGCGGCGCGGAGCAGCCGACGCACGCTAGTGGGTCCGCCCGCCACCGCCCCTTCCTCGGCGTCCGCTCCCG
CCCTTGCCGTCCCCCGCGCGGCTCCGCGCCTCGGGCCCCGGGCGCAGCCAGCCCTCCAGACGCCCGCGGTCCCGGCGGCGTGTGCTGCTC
TTCCTCCGCCCGCGGTTTCCAGCGCCGCTCCTTCCCCCGCTTGGGCAGGGAGGGGGCATTGATCTTCGATCGCGAAGATGGCTGCTGGCT
GCCTGCTGGCCTTGACTCTGACACTTTTCCAATCTTTGCTCATCGGCCCCTCGTCGGAGGAGCCGTTCCCTTCGGCCGTCACTATCAAAT
CATGGGTGGATAAGATGCAAGAAGACCTTGTCACACTGGCAAAAACAGCAAGTGGAGTCAATCAGCTTGTTGATATTTATGAGAAATATC
AAGATTTGTATACTGTGGAACCAAATAATGCACGCCAGCTGGTAGAAATTGCAGCCAGGGATATTGAGAAACTTCTGAGCAACAGATCTA
AAGCCCTGGTGCGGTTAAGAAGATTGTCTACCAAATATAGAACAGAAAAGATATATCCCACAGCCACTGGAGAAAAAGAAGAAAATGTTA
AAAAGAACAGATACAAGGACATACTGCCATTTGATCACAGCCGAGTTAAATTGACATTAAAGACTCCTTCACAAGATTCAGACTATATCA
ATGCAAATTTTATAAAGGGCGTCTATGGGCCAAAAGCATATGTAGCAACTCAAGGACCTTTAGCAAATACAGTAATAGATTTTTGGAGGA
TGATATGGGAGTATAATGTTGTGATCATTGTAATGGCCTGCCGAGAATTTGAGATGGGAAGGAAAAAATGTGAGCGCTATTGGCCTTTGT
ATGGAGAAGACCCCATAACGTTTGCACCATTTAAAATTTCTTGTGAGGATGAACAAGCAAGAACAGACTACTTCATCAGGACACTCTTAC
TTGAATTTCAAAATGAATCTCGTAGGCTGTATCAGTTTCATTATGTGAACTGGCCAGACCATGATGTTCCTTCATCATTTGATTCTATTC
TGGACATGATAAGCTTAATGAGGAAATATCAAGAACATGAAGATGTTCCTATTTGTATTCATTGCAGTGCAGGCTGTGGAAGAACAGGTG
CCATTTGTGCCATAGATTATACGTGGAATTTACTAAAAGCTGGGAAAATACCAGAGGAATTTAATGTATTTAATTTAATACAAGAAATGA
GAACACAAAGGCATTCTGCAGTACAAACAAAGGAGCAATATGAACTTGTTCATAGAGCTATTGCCCAACTGTTTGAAAAACAGCTACAAC
TATATGAAATTCATGGAGCTCAGAAAATTGCTGATGGAGTGAATGAAATTAACACTGAAAACATGGTCAGCTCCATAGAGCCTGAAAAAC
AAGATTCTCCTCCTCCAAAACCACCAAGGACCCGCAGTTGCCTTGTTGAAGGGGATGCTAAAGAAGAAATACTGCAGCCACCGGAACCTC
ATCCAGTGCCACCCATCTTGACACCTTCTCCCCCTTCAGCTTTTCCAACAGTCACTACTGTGTGGCAGGACAATGATAGATACCATCCAA
AGCCAGTGTTGCATATGGTTTCATCAGAACAACATTCAGCAGACCTCAACAGAAACTATAGTAAATCAACAGAACTTCCAGGGAAAAATG
AATCAACAATTGAACAGATAGATAAAAAATTGGAACGAAATTTAAGTTTTGAGATTAAGAAGGTCCCTCTCCAAGAGGGACCAAAAAGTT
TTGATGGGAACACACTTTTGAATAGGGGACATGCAATTAAAATTAAATCTGCTTCACCTTGTATAGCTGATAAAATCTCTAAGCCACAGG
AATTAAGTTCAGATCTAAATGTCGGTGATACTTCCCAGAATTCTTGTGTGGACTGCAGTGTAACACAATCAAACAAAGTTTCAGTTACTC
CACCAGAAGAATCCCAGAATTCAGACACACCTCCAAGGCCAGACCGCTTGCCTCTTGATGAGAAAGGACATGTAACGTGGTCATTTCATG
GACCTGAAAATGCCATACCCATACCTGATTTATCTGAAGGCAATTCCTCAGATATCAACTATCAAACTAGGAAAACTGTGAGTTTAACAC
CAAGTCCTACAACACAAGTTGAAACACCTGATCTTGTGGATCATGATAACACTTCACCACTCTTCAGAACACCCCTCAGTTTTACTAATC
CACTTCACTCTGATGACTCAGACTCAGATGAAAGAAACTCTGATGGTGCTGTGACCCAGAATAAAACTAATATTTCAACAGCAAGTGCCA
CAGTTTCTGCTGCCACTAGTACTGAAAGCATTTCTACTAGGAAAGTATTGCCAATGTCCATTGCTAGACATAATATAGCAGGAACAACAC
ATTCAGGTGCTGAAAAAGATGTTGATGTTAGTGAAGATTCACCTCCTCCCCTACCTGAAAGAACTCCTGAATCGTTTGTGTTAGCAAGTG
AACATAATACACCTGTAAGATCGGAATGGAGTGAACTTCAAAGTCAGGAACGATCTGAACAAAAAAAGTCTGAAGGCTTGATAACCTCTG
AAAATGAGAAATGTGATCATCCAGCGGGAGGTATTCACTATGAAATGTGCATAGAATGTCCACCTACTTTCAGTGACAAGAGAGAACAAA
TATCAGAAAATCCAACAGAAGCCACAGATATTGGTTTTGGTAATCGATGTGGAAAACCCAAAGGACCAAGAGATCCACCTTCAGAATGGA
CATGATTCAGGGAGCTAGAAGACACTTTAAGTTATACTGGAAAATTCAGGTGCCACTGAAAGCCAGATTTATAGTATTCCATCTTTAATA
TGTGGGACTAACAGCAGTGTAGATTGTTACCTTAATATTTTTTGCTGGGACCATCTACCTGCCTTATACTACACTTAGGAAAAAGTATTA
CATATGGTTTATTTTGAAACTTCAAGTATTATTGCCTTAATGTCTCTTAACCCTGTTACACGCTGCTTGTAGACATGTTAATATAGTAAT
ACCTTTATGATATATTGAGTTTAAGGACTACTCTTTTTCTGTTTTATCATGTATGCATTATTTTGTATATGTACAGGGCAAGTAGGTATA
TAATTTGATAAAGTTGCAATTGAAATATTATTAACAGAAGATGTAAGAAATTTCTGCATGGTCTAAATCTTTGTGTACTTTATTTGTAAA
TTATTTGCCCTGGAGTTTTAGAAAATAGTTTCTGAATTTTAAACTTGCTGGATTCATGCAGCCAGCTTTGCAGGTTATCAGAGATCAAAG
ATTGTAATAATAATTTTGTAAATTGTAAGCAAAAAGTTATTTTTATATTATATACAGTCTAATTGTTCATCCTAATTGTTCCTGTTTTCA
TCTAGTCAGAGATTCAGTAAGTGCCTTGGAACAATATTGAATTCTCTTAGCTTGTGTGTGTTTCTTTAATATTTGAACTCAAGTGGGATT

>In-frame_ENST00000423588_ENST00000248594_TCGA-K1-A6RT-01A_CACNA2D1_chr7_81964451_-_PTPN12_chr7_77200395_length(amino acids)=845AA_start in transcript=257_stop in transcript=2794
MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLL
SNRSKALVRLRRLSTKYRTEKIYPTATGEKEENVKKNRYKDILPFDHSRVKLTLKTPSQDSDYINANFIKGVYGPKAYVATQGPLANTVI
DFWRMIWEYNVVIIVMACREFEMGRKKCERYWPLYGEDPITFAPFKISCEDEQARTDYFIRTLLLEFQNESRRLYQFHYVNWPDHDVPSS
FDSILDMISLMRKYQEHEDVPICIHCSAGCGRTGAICAIDYTWNLLKAGKIPEEFNVFNLIQEMRTQRHSAVQTKEQYELVHRAIAQLFE
KQLQLYEIHGAQKIADGVNEINTENMVSSIEPEKQDSPPPKPPRTRSCLVEGDAKEEILQPPEPHPVPPILTPSPPSAFPTVTTVWQDND
RYHPKPVLHMVSSEQHSADLNRNYSKSTELPGKNESTIEQIDKKLERNLSFEIKKVPLQEGPKSFDGNTLLNRGHAIKIKSASPCIADKI
SKPQELSSDLNVGDTSQNSCVDCSVTQSNKVSVTPPEESQNSDTPPRPDRLPLDEKGHVTWSFHGPENAIPIPDLSEGNSSDINYQTRKT
VSLTPSPTTQVETPDLVDHDNTSPLFRTPLSFTNPLHSDDSDSDERNSDGAVTQNKTNISTASATVSAATSTESISTRKVLPMSIARHNI
AGTTHSGAEKDVDVSEDSPPPLPERTPESFVLASEHNTPVRSEWSELQSQERSEQKKSEGLITSENEKCDHPAGGIHYEMCIECPPTFSD

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for CACNA2D1-PTPN12


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with
TgenePTPN12chr7:81964451chr7:77200395ENST00000248594018345_43833.0781.0TGFB1I1
TgenePTPN12chr7:81964451chr7:77200395ENST00000435495017345_4380651.0TGFB1I1


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for CACNA2D1-PTPN12


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational

Top

Related Diseases for CACNA2D1-PTPN12


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneCACNA2D1C1142166Brugada Syndrome (disorder)6CLINGEN;GENOMICS_ENGLAND;ORPHANET
HgeneCACNA2D1C0027796Neuralgia4CTD_human
HgeneCACNA2D1C0038870Neuralgia, Supraorbital4CTD_human
HgeneCACNA2D1C0042656Neuralgia, Vidian4CTD_human
HgeneCACNA2D1C0234247Neuralgia, Atypical4CTD_human
HgeneCACNA2D1C0234249Neuralgia, Stump4CTD_human
HgeneCACNA2D1C0264893Nodal rhythm disorder4CLINGEN
HgeneCACNA2D1C0348626Other specified cardiac arrhythmias4CLINGEN
HgeneCACNA2D1C0423711Neuralgia, Perineal4CTD_human
HgeneCACNA2D1C0423712Neuralgia, Iliohypogastric Nerve4CTD_human
HgeneCACNA2D1C0428908Sinus Node Dysfunction (disorder)4CLINGEN
HgeneCACNA2D1C0751371Neuralgia, Ilioinguinal4CTD_human
HgeneCACNA2D1C0751372Nerve Pain4CTD_human
HgeneCACNA2D1C0751373Paroxysmal Nerve Pain4CTD_human
HgeneCACNA2D1C1399226Ectopic rhythm4CLINGEN
HgeneCACNA2D1C2748542CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)4CLINGEN
HgeneCACNA2D1C4551804Brugada Syndrome 14CLINGEN
HgeneCACNA2D1C0020429Hyperalgesia3CTD_human
HgeneCACNA2D1C0458247Allodynia3CTD_human
HgeneCACNA2D1C0751211Hyperalgesia, Primary3CTD_human
HgeneCACNA2D1C0751212Hyperalgesia, Secondary3CTD_human
HgeneCACNA2D1C0751213Tactile Allodynia3CTD_human
HgeneCACNA2D1C0751214Hyperalgesia, Thermal3CTD_human
HgeneCACNA2D1C2936719Mechanical Allodynia3CTD_human
HgeneCACNA2D1C0003811Cardiac Arrhythmia1GENOMICS_ENGLAND
HgeneCACNA2D1C0007102Malignant tumor of colon1CTD_human
HgeneCACNA2D1C0009375Colonic Neoplasms1CTD_human
HgeneCACNA2D1C0011071Sudden death1GENOMICS_ENGLAND
HgeneCACNA2D1C0020538Hypertensive disease1CTD_human
HgeneCACNA2D1C0030193Pain1CTD_human
HgeneCACNA2D1C0151879Shortened QT interval1GENOMICS_ENGLAND
HgeneCACNA2D1C0234230Pain, Burning1CTD_human
HgeneCACNA2D1C0234238Ache1CTD_human
HgeneCACNA2D1C0234254Radiating pain1CTD_human
HgeneCACNA2D1C0458257Pain, Splitting1CTD_human
HgeneCACNA2D1C0458259Pain, Crushing1CTD_human
HgeneCACNA2D1C0751407Pain, Migratory1CTD_human
HgeneCACNA2D1C0751408Suffering, Physical1CTD_human
HgeneCACNA2D1C1865020Short QT Syndrome 11ORPHANET
TgenePTPN12C0007102Malignant tumor of colon1GENOMICS_ENGLAND;UNIPROT